摘要
目的探讨清开灵联合干扰素(IFN2α)治疗儿童病毒性脑炎的临床疗效及安全性。方法病毒性脑炎患儿174例,按入院顺序先后随机分为两组,两组均肌肉注射干扰素及常规予以退热、止惊、降颅压及支持治疗,治疗组加用清开灵静脉滴注,比较两组临床疗效及不良反应。结果临床显效率治疗组高于对照组(P<0.005)。不良反应发生率两组无显著性差异(P>0.05)。结论清开灵辅助干扰素治疗儿童病毒性脑炎临床疗效好,无明显不良反应。
Objective To observe the clinical efficacy and safety of ＂Qingkailing Injection＂ plus interferon （IFN2α） in the treatment of childhoad viral encephalitis. Methods 174 subjects were randomized in admission sequence into two groups and routinely treated. Besides, treatment group was additionally treated by intravenous injection of ＂Qingkailing Injection＂. Results The marked effective rate was higher in treatment group than in control group （P 〈 0.005）＂ there was no difference in side effects between two groups （P 〉 0.05）. Conclusion ＂Qingkailing Injection＂ helps well in the treatment of childhood viral encephalitis, with no side effects.
出处
《上海中医药杂志》
北大核心
2007年第3期30-31,共2页
Shanghai Journal of Traditional Chinese Medicine
关键词
病毒性脑炎
儿童
清开灵
干扰素
Viral encephalitis
child： ＂Qingkailing Injection＂
interferon
